Cargando…

Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis

Introduction: Mortality associated with invasive group A streptococcal infections (iGAS) remains high among adults, with lower mortality in children. The added value of both clindamycin and immunoglobulins in such treatment is still controversial, as is the need for antibiotic secondary prophylaxis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Laho, Delphine, Blumental, Sophie, Botteaux, Anne, Smeesters, Pierre R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417895/ https://www.ncbi.nlm.nih.gov/pubmed/34490159 http://dx.doi.org/10.3389/fped.2021.697938

Ejemplares similares

Clindamycin but not Intravenous Immunoglobulins reduces mortality in a retrospective cohort of critically ill patients with bacteremic Group A Streptococcal infections
por: Fernández-Galilea, Adela, et al.
Publicado: (2022)

Incidence and clinical and microbiological features of invasive and probable invasive streptococcal group A infections in children and adults in the Brussels-Capital Region, 2005–2020
por: Zangarini, Lisa, et al.
Publicado: (2023)

Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis
por: Parks, Tom, et al.
Publicado: (2018)

Promiscuous evolution of Group A Streptococcal M and M-like proteins
por: Frost, Hannah R., et al.
Publicado: (2023)

Immunoglobulin A Nephropathy Presenting After Streptococcal Pharyngitis: A Case Report
por: Hutchinson, Stedrea, et al.
Publicado: (2023)

Editorial Commentary: Step on the GAS: Are We Almost There for Clindamycin and Intravenous Immunoglobulin?
por: Tan, Lionel K. K., et al.
Publicado: (2014)

1370. Role of Clindamycin Versus Linezolid for Serious Group A Streptococcal Infections
por: Heil, Emily, et al.
Publicado: (2021)

Use of intravenous immunoglobulin therapy in the treatment of septic shock, in particular severe invasive group A streptococcal disease
por: Raithatha, Ajay H., et al.
Publicado: (2012)

Specialty Grand Challenge In Pediatric Infectious Diseases
por: Lepage, Philippe, et al.
Publicado: (2017)

Late-Onset Group B Streptococcal Sepsis in Preterm Twins
por: Alallah, Jubara, et al.
Publicado: (2023)

Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
por: Li, Yining, et al.
Publicado: (2019)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
por: Van Anh, Khanh-Van Y., et al.
Publicado: (2020)

Randomized Clinical Trial of Intrapartum Clindamycin Cream for Reduction of Group B Streptococcal Maternal and Neonatal Colonization
por: Gibbs, R. S., et al.
Publicado: (1996)

Group A Streptococcal Pyomyositis in a Previously Healthy Six-year-old Girl
por: Tawfik, Daniel, et al.
Publicado: (2018)

Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches
por: Patras, Kathryn A., et al.
Publicado: (2018)

Identifying Group A Streptococcal Pharyngitis in Children Through Clinical Variables Using Machine Learning
por: Miyagi, Yoshifumi
Publicado: (2023)

Efficacy of Intravenous Immunoglobulin/Exchange Transfusion Therapy on Gestational Alloimmune Liver Disease
por: Yeh, Pai-Jui, et al.
Publicado: (2021)

Instituting CDC Draft Guidelines for Prophylaxis of Neonatal Group B Streptococcal Invasive Disease
por: Amstey, Marvin S.
Publicado: (1995)

Reducing Broad-Spectrum Antibiotic Treatment of Simple Group A Streptococcal Infections to Reduce Harm to the Microbiome
por: Sumibcay, Tyrone J, et al.
Publicado: (2021)

The Value of Intravenous Immunoglobulin Therapy in Idiopathic Inflammatory Myositis in the Current Transformed Era of Biologics
por: Patwardhan, Anjali
Publicado: (2020)

Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion
por: Okulu, Emel, et al.
Publicado: (2022)

Hemolytic anemia following intravenous immunoglobulins in children with PIMS-TS: Two case reports
por: Sedlin, E., et al.
Publicado: (2023)

Intravenous Methylprednisolone Pulse Therapy Versus Intravenous Immunoglobulin in the Prevention of Coronary Artery Disease in Children with Kawasaki Disease: A Randomized Controlled Trial
por: Aslani, Nahid, et al.
Publicado: (2022)

Comparison of Machine Learning Models for Prediction of Initial Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease
por: Kuniyoshi, Yasutaka, et al.
Publicado: (2020)

Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis
por: Yan, Fan, et al.
Publicado: (2020)

Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China
por: Huang, Hongbiao, et al.
Publicado: (2022)

The Epidemiology of Influenza Virus Infection and Group A Streptococcal Pharyngitis in Children Between 2011 and 2018 in an Outpatient Pediatric Clinic
por: Yildiz, Ismail, et al.
Publicado: (2023)

Intravenous immunoglobulin treatment improves multiple neuropsychiatric outcomes in patients with pediatric acute-onset neuropsychiatric syndrome
por: Eremija, Jelena, et al.
Publicado: (2023)

Detection of group a streptococcal pharyngitis by quantitative PCR
por: Dunne, Eileen M, et al.
Publicado: (2013)

Effectiveness and Safety of an Intravenous Immune Globulin (IVIG) Preparation in Post-exposure Prophylaxis (PEP) Against Measles in Infants
por: Kohlmaier, Benno, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease
por: Chen, Yongbing, et al.
Publicado: (2019)

Risk Factors of Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease: A Meta-Analysis of Case-Control Studies
por: Liu, Gengying, et al.
Publicado: (2020)

C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease
por: Tsai, Chih-Min, et al.
Publicado: (2020)

Circulating Immune Cell Profile and Changes in Intravenous Immunoglobulin Responsiveness Over the Disease Course in Children With Kawasaki Disease
por: Choi, In Su, et al.
Publicado: (2022)

Case report: A case of severe retropharyngeal edema after COVID-19 successfully treated with intravenous immunoglobulin
por: Suzuki, Takanori, et al.
Publicado: (2023)

Streptococcal Toxic Shock Syndrome in a Child With Venous Malformation
por: Yoshida, Taro, et al.
Publicado: (2022)

A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old
por: Wu, Shu, et al.
Publicado: (2019)

Value of blood inflammatory markers for predicting intravenous immunoglobulin resistance in Kawasaki disease: A systematic review and meta-analysis
por: Liu, Chang, et al.
Publicado: (2022)

Study on the relationship between intrapartum group B streptococcus prophylaxis and food allergy in children
por: Zhang, Hong, et al.
Publicado: (2022)

Prospective Cohort Study Investigating the Safety and Efficacy of Ambulatory Treatment With Oral Cefuroxime-Axetil in Febrile Children With Urinary Tract Infection
por: Hennaut, Elise, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fqdek5fuajbicmfuduc3tfr5vg